Items where authors include "Turner, M.R."

Article

Boddy, S.L., Simpson, R.M. orcid.org/0000-0003-1677-5938, Walters, S.J. et al. (38 more authors) (2025) Further development of a patient-reported outcome measure to assess the impact of oral secretion problems in people living with MND. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. ISSN 2167-8421

Benatar, M. orcid.org/0000-0003-4241-5135, McDermott, C. orcid.org/0000-0002-1269-9053, Turner, M.R. et al. (1 more author) (2025) Reply: Overstating harms can have consequences. Brain. awaf047. ISSN 0006-8950

Howard, J. orcid.org/0000-0001-7182-593X, Forrest Keenan, K., Mazanderani, F. et al. (2 more authors) (2025) Experiences of predictive genetic testing in inherited motor neuron disease: findings from a qualitative interview study. Journal of Genetic Counseling, 34 (1). e1904. ISSN 1059-7700

Yildiz, O., Hunt, G.P. orcid.org/0000-0002-5217-2678, Schroth, J. et al. (9 more authors) (2025) Lipid-mediated resolution of inflammation and survival in amyotrophic lateral sclerosis. Brain Communications, 7 (1). fcae402. ISSN 2632-1297

Benatar, M. orcid.org/0000-0003-4241-5135, McDermott, C. orcid.org/0000-0002-1269-9053, Turner, M.R. orcid.org/0000-0003-0267-3180 et al. (1 more author) (2024) Rethinking phase 2 trials in amyotrophic lateral sclerosis. Brain. awae396. ISSN 0006-8950

Benatar, M. orcid.org/0000-0003-4241-5135, Heiman-Patterson, T.D. orcid.org/0000-0002-9910-1041, Cooper-Knock, J. orcid.org/0000-0002-0873-8689 et al. (12 more authors) (2024) Guidance for clinical management of pathogenic variant carriers at elevated genetic risk for ALS/FTD. Journal of Neurology, Neurosurgery and Psychiatry, 96 (3). pp. 209-218. ISSN 0022-3050

Howard, J. orcid.org/0000-0001-7182-593X, Mazanderani, F., Keenan, K.F. et al. (2 more authors) (2024) Fluctuating salience in those living with genetic risk of motor neuron disease: A qualitative interview study. Health Expectations, 27 (2). e14024. ISSN 1369-6513

Cooper‐Knock, J., Julian, T.H., Feneberg, E. et al. (15 more authors) (2023) Atypical TDP-43 protein expression in an ALS pedigree carrying a p.Y374X truncation mutation in TARDBP. Brain Pathology, 33 (1). e13104. ISSN 1015-6305

Balendra, R., Jones, A.R., Al Khleifat, A. et al. (7 more authors) (2023) Comparison of King’s clinical staging in multinational amyotrophic lateral sclerosis cohorts. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 24 (1-2). pp. 71-81. ISSN 2167-8421

Yildiz, O., Schroth, J., Tree, T. et al. (4 more authors) (2023) Senescent-like blood lymphocytes and disease progression in amyotrophic lateral sclerosis. Neurology: Neuroimmunology & Neuroinflammation, 10 (1). ISSN 2332-7812

Alix, J.J.P. orcid.org/0000-0001-8391-9749, Verber, N.S., Schooling, C.N. et al. (5 more authors) (2022) Label-free fibre optic Raman spectroscopy with bounded simplex-structured matrix factorization for the serial study of serum in amyotrophic lateral sclerosis. The Analyst, 147 (22). pp. 5113-5120. ISSN 0003-2654

Gao, J., Dharmadasa, T., Malaspina, A. et al. (4 more authors) (2022) Creatine kinase and prognosis in amyotrophic lateral sclerosis: a literature review and multi-centre cohort analysis. Journal of Neurology, 269. pp. 5395-5404. ISSN 0340-5354

Jiménez-Villegas, J., Kirby, J. orcid.org/0000-0002-7468-5917, Mata, A. et al. (6 more authors) (2022) Dipeptide repeat pathology in C9orf72-ALS Is associated with redox, mitochondrial and NRF2 pathway imbalance. Antioxidants, 11 (10). 1897. ISSN 2076-3921

Thompson, A.G., Gray, E., Verber, N. et al. (20 more authors) (2022) Multicentre appraisal of amyotrophic lateral sclerosis biofluid biomarkers shows primacy of blood neurofilament light chain. Brain Communications, 4 (1). fcac029. ISSN 2632-1297

Shepheard, S.R., Parker, M.D. orcid.org/0000-0003-2999-3870, Cooper-Knock, J. orcid.org/0000-0002-0873-8689 et al. (15 more authors) (2021) Value of systematic genetic screening of patients with amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery & Psychiatry, 92 (5). pp. 510-518. ISSN 0022-3050

van den Berg, L.H., Sorenson, E., Gronseth, G. et al. (20 more authors) (2019) Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials. Neurology, 92 (14). e1610-e1623. ISSN 0028-3878

de Majo, M., Topp, S.D., Smith, B.N. et al. (30 more authors) (2018) ALS-associated missense and nonsense TBK1 mutations can both cause loss of kinase function. Neurobiology of Aging, 71. 266.e1-266.e10.

Westeneng, H.-J., Debray, T.P.A., Visser, A.E. et al. (44 more authors) (2018) Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model. Lancet Neurology, 17 (5). pp. 423-433. ISSN 1474-4422

Smith, B.N., Topp, S.D., Fallini, C. et al. (53 more authors) (2017) Mutations in the vesicular trafficking protein annexin A11 are associated with amyotrophic lateral sclerosis. Science Translational Medicine, 9 (388). eaad9157. ISSN 1946-6234

Strong, M.J., Abrahams, S., Goldstein, L.H. et al. (11 more authors) (2017) Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 18 (3-4). pp. 153-174. ISSN 2167-8421

Kenna, K.P., van Doormaal, P.T.C., Dekker, A.M. et al. (92 more authors) (2016) NEK1 variants confer susceptibility to amyotrophic lateral sclerosis. Nature Genetics, 48 (9). pp. 1037-1042. ISSN 1061-4036

McGeachan, A.J., Hobson, E.V., Al-Chalabi, A. et al. (19 more authors) (2016) A multicentre evaluation of oropharyngeal secretion management practices in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. ISSN 2167-8421

Oeckl, P., Jardel, C., Salachas, F. et al. (32 more authors) (2016) Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. pp. 1-10. ISSN 2167-8421

van der Kleij, L.A., Jones, A.R., Steen, I.N. et al. (6 more authors) (2015) Regionality of disease progression predicts prognosis in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration , 16 (7-8). pp. 442-447. ISSN 2167-8421

McDermott, C.J., Shaw, P.J., Stavroulakis, T. et al. (24 more authors) (2015) Gastrostomy in patients with amyotrophic lateral sclerosis (ProGas): a prospective cohort study. Lancet Neurology, 14 (7). pp. 702-709. ISSN 1474-4422

Smith, B.N., Ticozzi, N., Fallini, C. et al. (63 more authors) (2014) Exome-wide Rare Variant Analysis Identifies TUBA4A Mutations Associated with Familial ALS. Neuron, 84 (2). pp. 324-331. ISSN 0896-6273

Balendra, R., Jones, A., Jivraj, N. et al. (6 more authors) (2014) Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials. Journal of Neurology, Neurosurgery and Psychiatry, 86 (1). pp. 45-49. ISSN 0022-3050

Turner, M.R., Bowser, R., Bruijn, L. et al. (11 more authors) (2013) Mechanisms, models and biomarkers in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 14 (Sup1). pp. 19-32. ISSN 2167-8421

Turner, M.R., Hardiman, O., Benatar, M. et al. (17 more authors) (2013) Controversies and priorities in amyotrophic lateral sclerosis. The Lancet Neurology, 12 (3). pp. 310-322. ISSN 1474-4422

Preprint

Pham, T.K. orcid.org/0000-0002-8083-0631, Verber, N. orcid.org/0000-0002-1428-7917, Turner, M.R. orcid.org/0000-0003-0267-3180 et al. (4 more authors) (2024) Glutathione oxidation in cerebrospinal fluid as a biomarker of oxidative stress in Amyotrophic Lateral Sclerosis. [Preprint] (Submitted)